Anesthesia Monitoring Devices Market is Expected to Reach $1.9 Billion by 2024| Key Industry Participants Medtronic plc, GE Healthcare

San Francisco, 5 November 2018: The anesthesia monitoring devices market is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications.

The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period.

Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, microprocessor-based intelligent anesthesia systems with integrated monitors enables monitoring of various parameters along with the precisely-controlled administration of the anesthetic agent.

Access Research Report of Anesthesia Monitoring Devices Market @ www.grandviewresearch.com/industry-analysis/anesthesia-monitoring-devices-market

Further key findings from the study suggest:

·       Amongst the product type segments, the advanced anesthesia monitors segment held a lucrative share of over 60.0% in 2015 owing to its durability, reliability, and accuracy. Moreover, these devices monitor various significant parameters such as oxygen saturation level, carbon dioxide level, heart rate, and blood pressure.

·       The hospitals in the end-use segment exhibited remunerative growth in 2015; this can be attributed to the presence of advanced diagnostic and therapeutic medical technologies that enables both, faster and accurate diagnosis. Moreover, the availability of these advanced systems coupled with the presence of skilled personnel contributes towards profitable growth of this segment.

·       North America dominated the overall market with a revenue share of over 35.0% in 2015 owing to the presence of well-developed health care settings and the presence of a favorable reimbursement network, government funding, and increasing health awareness levels amongst the people.

·       However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 11.0% over the forecast period. The economic developments and the advancing healthcare system with the aid of supportive government initiatives are collectively anticipated to further assist the growth in this region.

·       Some key players operating in the anesthesia monitoring devices market include Masimo Corporation, Infinium Medical, Inc., Medtronic plc, GE Healthcare, Nihon Kohden Corporation, Philips Healthcare, Mindray Medical International Ltd., Drägerwerk AG & Co. KGaA, and Schiller AG. New product development, mergers, and collaborations are some key initiatives taken to sustain themselves in the competition.

·       For instance, Masimo Corporation incorporated Oxygen Reverse Index (ORI) which measures the oxygen levels and provides real-time information with regard to the patient’s oxygen reserve in synchronization with the partial pressure of oxygen to prevent hyperoxia conditions (oxygen levels above normal) in patients that are receiving auxiliary oxygen supply whilst undergoing surgery.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented anesthesia monitoring devices market on the basis of product type, end-use, and region.

Global Anesthesia Monitoring Devices Market By Product Revenue, (USD Million) 2013 - 2024

·         Advanced Anesthesia Monitors

o    Anesthesia Gas Monitors

o    Monitors Measuring Depth of Anesthesia

o    Standalone Capnography Monitors

o    Others

·         Basic Anesthesia Monitors

·         Integrated Anesthesia Monitors

Global Anesthesia Monitoring Devices Market By End-Use Revenue, (USD Million) 2013 - 2024

·         Hospitals

·         Ambulatory Settings

·         Others

Anesthesia Monitoring Devices Market By Region Revenue, (USD Million) 2013 - 2024

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Anesthesia Monitoring Devices Market@ www.grandviewresearch.com/press-release/global-anesthesia-monitoring-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Telemedicine Market to Reach $113.1 Billion by 2025| Top Industry Players Philips Healthcare, McKesson Corporation

San Francisco, 5 November 2018: According to a report by Grand View Research, Inc., global telemedicinemarket is predicted to value USD 113.1 billion by 2025. Growing requirement for advanced technology that can monitor various chronic conditions such as cardiovascular conditions, diabetes, and cancer is anticipated to propel demand for telemedicine. It is likely to deliver health education, health care, and health information at a distance. In addition, it can offer advanced patient centered care coupled with increased access to remote locations. Moreover, it can also reduce emergency room visit and hospitalization rate among patients.

Healthcare sector is enormously huge and its centralization is likely to support in harmonizing entire process as well as providing economic assistances. All businesses are likely to incorporate six sigma and lean management in their practice to enhance resource practice and increase efficiency. According to community care plan of eastern Carolina (CCP), installation of telehealth program is expected to allow clinicians and medical providers to attend over 20 patients in one week as compared to mere 10 before. Growing demand of patients to presume better and earlier healthcare provision coupled with increasing disposable income can propel growth of market.

Growing adoption of home care coupled with rising concerns to reduce hospital visits can influence growth of market. Rising cases of chronic disorders attributed to increasing number of geriatric population globally is likely to stimulate market growth. High demand for self-governing and healthy existence by patients can augment growth of market over next few years. Enhancing application of internet, virtual medicine and high demand for centralization of healthcare can fuel market growth during the forecast period (2014 to 2025).

Access Research Report of Telemedicine Market@ www.grandviewresearch.com/industry-analysis/telemedicine-industry

To cater to rising demand for telemedicine, most companies and research institutes are likely to get involved in R&D activities to develop advanced solutions. For instance, a team of researchers from Dell medical school at university of Texas recently observed that diabetic retinopathy screening via telemedicine is expected to have long-term benefits for patients in urban and remote areas. Researchers are expected to collect data on total number of patients screened to count number of patients who required further evaluation and those who got evaluated by trained retina specialists. According to data collected, 5764 patients are expected to receive screening in past years. Among them, 5632 are found to get gradual images. Another 1830 are expected to have retinal pathology and 1152 are likely to be diagnosed with diabetic retinopathy (DR).    

  

The telemedicine market can be segregated on the basis of product and region. Based on product, the market can be categorized into network & connectivity, hardware, and others. In 2016, hardware segment dominated the market and accounted for largest market share. The segment is likely to include products such as desktop, laptops, speakers, microphones, videoconferencing, webcams, and display monitors. Hardware used in telemedicine can abide to specific conditions that are required for its competent functioning. Hardware is likely to be graded and selected based on traits such as general memory & video, connectivity & email feature, and processor speed and display quality.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA). In 2016, North America accounted for significant 32.8 % of market share. United States is expected to be dominant attributed to prevalence of refined medical services in the country. In addition, supportive initiatives from local governments including introduction of incentive system by Medicaid and Medicare.

In Asia Pacific, the market is expected to witness substantial growth attributed to high demand for healthcare IT services in healthcare. In addition, rising investments from local governments to develop healthcare facilities can fuel market growth in the region.

In Latin America, the market is likely to grow well over the forecast period owing to rising demand for post-acute care supervision.

Some of the leading companies offering telemedicine are Philips Healthcare, IBM, McKesson Corporation, Intel Corporation, and AMD Telemedicine. Most companied are likely to adopt strategic actions such as new product launches and mergers & acquisitions to expand their work portfolio and gain traction among consumers.

Access Press Release of Telemedicine Market@ www.grandviewresearch.com/press-release/global-telemedicine-industry

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Textile Market To Make Great Impact in Near Future by 2025| Key Industry Participants INVISTA, Shandong Jining Ruyi Woolen Textile Co., Ltd

San Francisco, 5 November 2018: According to a report by Grand View Research, Inc.; the global textilemarket is predicted to value USD 193.16 billion by 2022. Textile is a flexible material formed using several processes including knitting, weaving, crocheting, or felting. It is used to manufacture a wide range of conventional and advanced finished goods used in kitchen, clothing, apparel, fashion, construction, bedding, transportation, and medical. High demand from these industries is the primary driver for the global market.

Growing population, urbanization, and disposable income in emerging economies such as India, China, and Mexico are expected to improve consumer lifestyle. This, in turn, can augment market growth during the forecast period (2014 to 2025). Growing awareness regarding protective equipment in manufacturing owing to stringent regulations aimed at worker safety can positively influence growth of market.

Increasing number of fashion retail outlets in emerging economies such as India and China attributed to support from local governments to promote investments can spur market expansion over the forecast period. Continual technological advancements in upholstery products derived from coated fabrics can also stimulate market growth in near future.

Access Research Report of Textile Market@ www.grandviewresearch.com/industry-analysis/textile-market

The global textile market can be segregated on the basis of raw material, product, application, and region. Based on raw material, the market can be categorized into chemical, cotton, wool, silk, and others. In 2015, cotton was most used raw material for production of textiles and accounted for around 39.5% market share in the same year. Properties such as high strength, excellent absorbency, and color retention can positively influence demand in the forthcoming years.

On the other hand, silk is expected to witness a CAGR of 4.6% from 2016 to 2025. Growing use of spider silk in formulation of industrial textile attributed to excellent toughness and lightweight as compared to steel is the predominant driver for this segment.

Based on product, the market for textiles can be classified into polyesters, nylon, natural-fibers, and others. In 2015, natural fibers segment accounted for 45.6% of overall market share in terms of volume. It is likely to grow well over the forecast period. High market visibility of cotton derived products in garments and apparels sector can fuel demand in near future.

On the contrary, nylon segment is estimated to register a CAGR of 4.5% from 2016 to 2025. Properties of nylon such as high resilience, low moisture absorbency, and excellent elasticity are anticipated to bode well for product demand over the forecast period.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/specialty-glass-ceramic-and-fiber

Based on application, the market is divided into technical, household, fashion and clothing, and others. In 2015, fashion and clothing segment dominated the market and accounted for a revenue share equivalent to USD 607.6 billion. It is expected to expand at a substantial CAGR during the forecast period.

New product launches by garment manufacturers including Tommy Hilfiger and Levis in Canada and United States can impel market expansion. In addition, rising sales volume of footwear and apparels through e-commerce portals like Amazon is expected to spur market development in near future.

Household application accounted for 9.6% of overall market share in terms of volume. Properties such as stain-repellent texture, wear and tear resistance, and ability to give soft and comfortable finishing to fabric surfaces is anticipated to impel product demand.

Regional segmentation includes Asia Pacific, Europe, North America, Central and South America, and Middle East and Africa. In 2015, Asia Pacific consumed 99,005.9 kilo tons of textiles and is predicted to witness significant growth over the forecast period. Positive outlook towards garments and apparel industry in India and China can fuel regional expansion in near future. In addition, favorable government policies to promote investments in manufacturing sector can further boost market growth.

Similarly, North America is likely to register a CAGR of 2.7% from 2016 to 2025 attributed to rising production of automotive vehicles in United States. Rising number of single family houses is expected to further augment regional market growth over the forecast period.

Middle East and Africa is predicted to expand at CAGR of 3.6% in the forthcoming years. Growing investments by Islamic clothing manufacturers to produce new hijab styles in apparels can propel regional demand for textiles during the forecast period.

Some of the leading companies operating in textiles market are Asahi Kasei Fibers Corporation, INVISTA, Shandong Jining Ruyi Woolen Textile Co., Ltd., Honeywell International, and Sinopec Yizheng Chemical Fiber Company.

Access Press Release of Textile Market@ www.grandviewresearch.com/press-release/global-textile-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Atopic Dermatitis Drugs Market Size is Expected to Reach $6.41 Billion by 2022| Key Industry Participants Mylan, Pfizer

San Francisco, 5 November 2018: The global atopic dermatitis drugs market size is expected to reach USD 6.41 billion by 2022, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.6% during the forecast period. Various factors such as emergence of novel therapeutics and growing uptake of targeted therapies are stimulating the growth of the market.

Eucrisa (Pfizer; crisaborole ointment) was approved by the U.S. FDA for treatment of atopic dermatitis (AD), in 2016. The drug is indicated for mild-to-moderate AD in patients who are two years or older, meeting a key therapeutics need of the market. Dupixent (Sanofi/Regeneron) was the first biologic to be launched in 2017 for management of AD. The drug is under clinical investigation for use in pediatric population.

Several promising candidates, especially biologics and small molecules, in pipeline are expected to alter the AD therapeutic landscape post launch. Nemolizumab is anticipated to be the first biologic (anti-IL-13) indicated for itching associated with atopic dermatitis. Tralokinumab, an IL-13 inhibitor, is under evaluation for safety and efficacy of treatment of moderate-to-severe AD.

Upcoming patent expiration of key products, such as LEO Pharma’s Protopic, Mylan/Valeant’s Elidel, and Bayer’s Desonate will result in generic penetration in therapeutic space. However, novel therapeutics, such as Eucrisa and Dupixent, are likely to gain traction over the forecast period and attain blockbuster status.

Underdeveloped and unserved categories such as rarer subtypes and pediatric population offer strong commercial opportunities. Drug companies are currently investigating multiple treatment options in niche indications such as severe refractory atopic dermatitis. Improving availability of new treatment modalities and targeted approaches offer a promising future for the global atopic dermatitis drugs market.

Access Research Report of Atopic Dermatitis Drugs Market @ www.grandviewresearch.com/industry-analysis/atopic-dermatitis-drugs-market

Further key findings from the report suggest:

·       Corticosteroids dominated the drug class in 2016, owing to their indication as first-line therapeutics for atopic dermatitis

·       Recent launch of biologics and small molecules such as Dupixent and Eucrisais likely to change the current therapeutic scenario due to their target-oriented mechanism of action

·       Calcineurin inhibitors are likely to witness stifled growth because of adverse effects, non-specificity, and development of resistance to chemical agents

·       The U.S. was the leading regional market in 2016. It is posed to maintain its position through 2022, owing to burgeoning disease burden, increasing treatment rate, and high drug cost

·       The topical segment led the atopic dermatitis drugs market in 2016, based on route of administration. Although the segment is expected to continue leading the market through 2022, Dupixent’s launch in 2017 marked the arrival of injectable. The new RoA is anticipated to hold approximately 30.0% market share by 2022

·       Bayer, LEO Pharma, Mylan, Pfizer, and Sanofi are some of key players operating in the market

·       Pfizer and Sanofi are anticipated to be leaders in AD therapeutic space by 2022 due to growing adoption of targeted therapies, such as Eucrisa and Dupixent

·       Rarer subtypes, such as severe refractory atopic dermatitis, have few treatment options available and lack a significant pipeline. This field presents a strong commercial opportunity to drug developers.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global atopic dermatitis drugs market based on drug class, route of administration, and region:

Atopic Dermatitis Drugs Class Outlook (Revenue, USD Million, 2016 - 2022)

·         Corticosteroids

·         Calcineurin Inhibitors

·         PDE4 Inhibitors

·         Biologics

·         Others

Atopic Dermatitis Drugs Route of Administration Outlook (Revenue, USD Million, 2016 - 2022)

·         Topical

·         Injectable

·         Oral

Atopic Dermatitis Drugs Regional Outlook (Revenue, USD Million, 2016 - 2022)

·         U.S.

·         U.K.

·         Germany

·         Spain

·         France

·         Italy

·         Japan

Access Press Release of Atopic Dermatitis Drugs Market@ www.grandviewresearch.com/press-release/global-atopic-dermatitis-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Organic Seed Market to Surpass $4.59 Billion by 2022| Top Industry Players Fleuren, Johny

San Francisco, 2 November 2018: The global organic seed market is expected to reach USD 4.59 billion by 2022, according to a new report by Grand View Research, Inc. Growing health consciousness and environmental awareness have resulted in shift in consumer preferences towards organic food. Such trends are projected to complement the organic seed market in the near future. Organic food products are devoid of any chemical exposure and are thus healthier than their conventional counterparts. Rising disposable income and increasing market penetration are key factors that are expected to aid the organic seed market particularly in the emerging markets of Asia Pacific and Central & South America. 

High organic seed cost is anticipated to act as a major deterrent for market growth and development. Lack of awareness, high demand-supply imbalance and lower awareness regarding organic food products are some other challenges faced by market participants. Unavailability of high quality and certified organic seeds is another prominent factor that is anticipated to negatively impact the regional as well as global market over the next seven years. Technological advancements, better value chain management and wide distribution network are a few areas which offer ample growth opportunities to the industry participants over the forecast period. 

Access Research Report of Organic Seed Market@ www.grandviewresearch.com/industry-analysis/organic-seeds-market

Further key findings from the report suggest:

·       Global organic seed market was valued at USD 1,698.5 million in 2014 and is expected to be valued at USD 4,593.6 million in 2022, growing at an estimated CAGR of 13.6% from 2014 to 2022.

·       Vegetable seeds dominated the global market and accounted for over 30% of total revenue in 2014. They are also expected to witness the highest growth rate over the forecast period.

·       North America dominated the global organic seed market with demand share estimated at 35.7% in 2014. Asia Pacific is projected to witness the highest growth of 14.3% from 2015 to 2022. Growing awareness regarding benefits offered by organic seed particularly in China and India is expected to drive the regional market over the forecast period.  

·       The industry is segmented and is characterized by high industry rivalry owing to the presence of numerous industry participants. Region specific organic seed producers play a critical role across the value chain. There is considerable supply-demand gap which has arisen due to the brisk growth in demand for organic food products in the recent past.

·       Key industry participants operating in the global market include Seed Savers Exchange, Wild Garden Seeds, Fleuren, Johny;s Selected Seeds, Navdanya, Maas Plant, Seeds of Change, Fedco Seeds and Vitalis Organic Seeds.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the organic seed market on the basis of product and region:

Global Organic Seed Product Outlook (Revenue, USD Million, 2012 - 2022)

·         Vegetable Seeds

·         Field Crop Seeds

·         Fruit & Nuts

·         Other Vegetation

Global Organic Seed Regional Outlook (Revenue, USD Million, 2012 - 2022)

·         North America

·         Europe

·         Asia Pacific

·         Central & South America

·         Middle East & Africa

Access Press Release of Organic Seed Market@ www.grandviewresearch.com/press-release/global-organic-seed-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com